Table 1.
Characteristic | Patients Randomly Assigned to No Fresh Fruits and Vegetables (cooked diet; n = 78) |
Patients Randomly Assigned to Fresh Fruits and Vegetables (raw diet; n = 75) |
Patients Not Randomly Assigned (preferred cooked diet; n = 53) |
P | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |||||
Age, years | .62 | |||||||||
Median | 64 | 63 | 66 | |||||||
Range | 17-88 | 47-84 | 49-81 | |||||||
ERM score | ||||||||||
25th percentile | 0.05 | 0.05 | 0.05 | .98 | ||||||
Median | 0.11 | 0.14 | 0.12 | |||||||
75th percentile | 0.25 | 0.26 | 0.32 | |||||||
Disease | .63 | |||||||||
AML | 75 | 69 | 51 | |||||||
MDS | 3 | 6 | 2 | |||||||
Voriconazole prophylaxis | 14 | 18 | 8 | 11 | 0 | .005* | ||||
Chemotherapy | ||||||||||
With cytarabine | 65 | 83 | 52 | 69 | 40 | 75 | .13† | |||
Idarubicin + cytarabine ± tipifarnib | 32 | 24 | 21 | |||||||
Clofarabine + cytarabine | 20 | 18 | 16 | |||||||
Fludarabine + cytarabine | 10 | 9 | 3 | |||||||
Without cytarabine | 13 | 17 | 23 | 31 | 13 | 25 | ||||
Clofarabine | 3 | 11 | 2 | |||||||
VNP40101M | 4 | 8 | 8 | |||||||
High dose | 70 | 90 | 70 | 93 | 50 | 94 | .64 | |||
Targeted | 8 | 10 | 5 | 7 | 3 | 6 | ||||
No. of days on study | .27 | |||||||||
Median | 24 | 24 | 24 | |||||||
Range | 10-47 | 6-42 | 8-45 |
Abbreviations: ERM, early risk of mortality; AML, acute myeloid leukemia; MDS, myelodysplastic syndrome.
P = .25 for comparison of cooked v raw groups.
P = .06 for comparison of cooked v raw groups.